Anodyne Nanotech

Anodyne Nanotech, Inc. is a preclinical-stage biotechnology company dedicated to developing differentiated transdermal formulations of high-value drugs. The company's macroporous microneedle technology provides the first practical and cost-effective platform, Hero Patch, capable of delivering clinically meaningful doses of large molecule drugs, such as monoclonal antibodies, or small molecules (e.g., ibuprofen), for rapid and sustained delivery.